Brief: Cortexyme Announces Agreement To Acquire Novosteo

IRulya Therapeutics

10/05/2022 13:09

May 10 (Reuters) - Cortexyme Inc  CRTX.O :
    * CORTEXYME ANNOUNCES AGREEMENT TO ACQUIRE NOVOSTEO
    * SAYS UPON COMPLETION OF TRANSACTION, NOVOSTEO STOCKHOLDERS
WILL
OWN APPROXIMATELY 15.5% OF COMBINED COMPANY
    * NOVOSTEO STOCKHOLDERS WILL OWN APPROXIMATELY 15.5% OF
COMBINED
COMPANY
    * UPON CLOSE, CO WILL APPOINT NOVOSTEO EXECUTIVES DIRK THYE
AS
CHIEF EXECUTIVE OFFICER
    * COMPANY PLANS TO OPERATE UNDER NEW NAME - QUINCE
THERAPEUTICS
INC - AND BEGIN TRADING UNDER TICKER SYMBOL "QNCX"

Source text for Eikon:  ID:nBw5vCFv5a 
Further company coverage:  CRTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))